Inari Medical Sees FY24 Revenue $594.5M-$604.5M Vs $708M Estimate
Portfolio Pulse from Benzinga Newsdesk
Inari Medical has raised its full-year 2024 revenue guidance to $594.5 million to $604.5 million, up from the previous range of $592.5 million to $602.5 million. This reflects a growth of approximately 20.5% to 22.5% over 2023. The company expects to achieve sustained operating profitability in the first half of 2025.
July 30, 2024 | 8:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Inari Medical has increased its full-year 2024 revenue guidance to $594.5 million to $604.5 million, indicating a growth of 20.5% to 22.5% over 2023. The company also expects to achieve sustained operating profitability in the first half of 2025.
The increase in revenue guidance and the expectation of sustained operating profitability are positive indicators for Inari Medical. This suggests strong business performance and growth potential, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100